Multiple organ inflammation is a hallmark of systemic autoimmune disorders, which can have disastrous effects on patients. Treatments for these disorders are desperately needed. In some clinical trials, RNase therapies appear promising, but not in all. The causes of this variability have bee
Marlborough (Massachusetts) [US], June 29: Quantiphi, an award-winning, AI-first digital engineering company founded on the premise of solving what matters most to business through responsible AI, today announced the launch of Digital Animal Replacement Technology (DART), a groundbreaking so
Mumbai (Maharashtra) [India], June 21: With over 30 million* people in India, suffering from chronic respiratory disorders of COPD and Asthma, there is a critical unmet need to look at new gen technologies to manage the chronic disease conditions and improve the quality of life of patient
Researchers found cancer cells can adapt to new drugs called CDK2 inhibitors in 1-2 hours, but adding a second drug squelches the workaround. The study was published in Journal, 'Cell.'
Researchers found some monoclonal antibodies used in clinical trials have been linked to life-threatening systemic fungal infections.
The study was published in Journal, 'Cell.'
Researchers discovered that 42 percent of patients with metastatic brain cancer benefited from the immune checkpoint inhibitor pembrolizumab in a phase 2 clinical study, with seven patients living for more than two years. The authors emphasise that these advantages must be balanced against t
When compared to patients receiving standard of care, the DIALIVE device, developed by researchers at UCL's Institute for Liver and Digestive Health, was found to be safe and associated with significant improvement in the severity of symptoms
A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Centre (VRC), which is part of the National Institutes of Health, has begun at Duke University in Durham, North Carol
It has been proven safe and effective in numerous clinical trials involving patients whose MDD does not respond to antidepressant medication. Conventionally, rTMS is given once daily 20 to 30 days over four to six weeks. That places great time demands on both patients and clinicians.
According to a new study, therapeutic hypothermia, the sole evidence-based treatment for neonates born with neonatal encephalopathy (NE) at or after 36 weeks, is ineffective for lowering death or moderate/severe damage in newborns born between 33 and 35 weeks.
Dogs with dementia experience the same sleep interruptions as people with dementia. North Carolina State University researchers used electroencephalography, or EEGs, on senior dogs to see if brain-wave readings during sleep linked with indicators of cognitive deterioration. They discovered t
According to the reports of the largest study, active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery.